Temporary professional services
Ended Awarded Last action
- Contract number
- 75F40123F19309
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $49,531
Award facts
- Contract value 100% obligated
- $49,531.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20903, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$20,928 | |
| Other Administrative Action | $0 | |
| Original award | $70,460 |
About this award
The Food and Drug Administration awarded a $49.5K call under a Professional and Technical Services Blanket Purchase Agreement (BPA) to Brillient Corporation, a minority-owned digital transformation firm, with performance completed by August 24, 2024. This contract call, issued on August 25, 2023, is structured as a labor-hour engagement performed in Silver Spring, Maryland, and represents a specific task order drawn from a larger BPA vehicle under the General Services Administration's Multiple Award Schedule. The award carries no set-aside designation despite the contractor's minority-owned business status.
Brillient Corporation, a Subchapter S Corporation, is an established provider of professional and technical services to federal agencies, with particular expertise in program management, IT services, engineering, consulting, and administrative support. The company maintains significant presence across the federal government, including major contract vehicles such as a $55.3M BPA with the Department of Treasury's Internal Revenue Service and a $58.5M indefinite delivery contract with the National Institutes of Health. As a certified vendor on the GSA's OASIS contract—a government-wide acquisition vehicle valued at $999.9B—Brillient is positioned to deliver comprehensive professional services across multiple federal agencies, making this FDA engagement consistent with its broader federal contracting portfolio.
Quick answers
Who was awarded contract 75F40123F19309?
75F40123F19309 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on August 25, 2023.
How much is contract 75F40123F19309 worth?
The government has obligated $49,531 on 75F40123F19309.
Is contract 75F40123F19309 an order under another contract?
Yes. 75F40123F19309 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40123F19309 competed?
The extent of competition for 75F40123F19309 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award